Device Trial Radar · NCT03775980
CIRSE Emprint Microwave Ablation Registry
Last checked: Nov 19, 2026Latest source record: May 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
500
Actual
Start
Sep 4, 2019
Primary completion
Jan 3, 2023
Study completion Jan 31, 2026
Sponsor
- Lead sponsor
- Cardiovascular and Interventional Radiological Society of EuropeAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Medtronic
- First posted
- Dec 14, 2018
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Observation of the clinical use of the Emprint Microwave Ablation System for the ablation of Liver Metastases of Colorectal Adenocarcinoma.
Conditions
- Colorectal Neoplasms Malignant
- Neoplasm Metastasis
Interventions
Emprint Microwave Ablation SystemDevice
Microwave Ablation of colorectal liver metastases
Primary outcomes
What the sponsor says the trial is designed to measure.
- Local Tumor ControlTime frame: 12 months
Locations
38 sites in 13 countries. Site status is shown where the registry gives one.
University Hospital Centre Sisters of Mercy
Zagreb, Croatia
Aarhus University Hospital
Aarhus, Denmark
University Hospital of Nimes
Nîmes, France
35 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.